HXCX(SZ:300300)2023-04-27 16:00Financial Performance - The company's operating revenue for 2022 was approximately ¥163.86 million, a decrease of 65.44% compared to ¥474.08 million in 2021[23]. - The net loss attributable to shareholders for 2022 was approximately ¥176.34 million, an improvement of 51.47% from a loss of ¥363.38 million in 2021[23]. - The net cash flow from operating activities was approximately ¥13.48 million, a significant increase of 113.03% compared to a negative cash flow of ¥103.40 million in 2021[23]. - The basic earnings per share for 2022 was -¥0.26, improving by 51.85% from -¥0.54 in 2021[23]. - Total assets at the end of 2022 were approximately ¥1.34 billion, a decrease of 16.22% from ¥1.60 billion at the end of 2021[23]. - The net assets attributable to shareholders at the end of 2022 were approximately ¥369.30 million, down 31.91% from ¥542.38 million at the end of 2021[23]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, was -¥64,828,919.63 for the year, compared to -¥11,270,995.23 in 2021, indicating a worsening financial performance[27]. - The company reported a net cash flow from operating activities of -¥1,943,282.76 in 2022, down from ¥5,625,732.66 in 2021, reflecting challenges in cash generation[27]. - In the fourth quarter of 2022, the operating revenue was ¥44,918,953.45, with a net loss attributable to shareholders of -¥100,142,555.32, highlighting ongoing financial difficulties[26]. Strategic Focus - The company aims to optimize its strategic layout and focus on its core business amidst industry growth[3]. - The company continues to focus on smart city and smart healthcare as its two main strategic areas, with smart city being the core business[36]. - The smart healthcare sector is identified as a strategic industry for future growth, with efforts to optimize business models and expand into new areas[38]. - The company is actively pursuing digital healthcare initiatives through its subsidiary, aiming to leverage unique regional advantages for market expansion[39]. - The company aims to leverage the "14th Five-Year Plan" development opportunities in Pingtan, actively participating in projects like 5G construction and the new smart island initiative[44]. Revenue Breakdown - Revenue from the Smart City and Finance segment was ¥130,626,664.66, accounting for 79.72% of total revenue, down 68.45% year-over-year[54]. - Revenue from the Smart Healthcare and Business segment was ¥33,237,169.58, representing 20.28% of total revenue, a decline of 44.70% compared to the previous year[54]. - Domestic revenue was ¥163,863,834.24, which constituted 100% of total revenue, reflecting a 65.38% decrease from ¥473,276,392.02 in 2021[54]. Research and Development - Research and development expenses decreased by 46.49% to ¥14,485,096.11 from ¥27,067,604.27 in 2021[62]. - The number of R&D personnel decreased by 41.11% to 53 from 90 in 2021[66]. - R&D investment amounted to ¥14,485,096.11, which is 8.84% of the operating revenue[66]. - The company aims to enhance its market competitiveness in smart healthcare through the development of a health consultation service platform for Taiwanese compatriots in mainland China[63]. Governance and Compliance - The company held five shareholder meetings during the reporting period, including one annual general meeting, ensuring compliance with regulations and protecting minority shareholders' rights[117]. - The board of directors consists of 9 members, including 3 independent directors, meeting the legal requirements for governance structure[118]. - The supervisory board has 3 members, including 1 employee representative, and held 7 meetings during the reporting period to oversee major company matters[120]. - The company maintains independent operations from its controlling shareholder, Pingtan State-owned Assets Supervision and Administration Commission, ensuring no interference in decision-making[121]. - The company adheres to strict information disclosure practices, ensuring timely and accurate communication with investors[122]. Market Challenges - The entertainment segment faced challenges, with a reduction of three self-operated cinemas due to industry downturns, prompting operational adjustments to minimize losses[50]. - The company faces risks from external market competition and economic uncertainties, which may impact business operations and revenue collection[107]. - The company is exploring new business areas while managing the uncertainties associated with new ventures, ensuring alignment with national policies and market adaptability[108]. Asset Management - The total financial assets at the beginning of the period were CNY 254,625,842.20, with a decrease of CNY 65,186,139.18 during the period, resulting in an ending balance of CNY 184,994,055.71[78]. - The company has no significant changes in the measurement attributes of major assets during the reporting period, indicating consistency in asset valuation[78]. - The company has maintained its independence in personnel, assets, and financial management, ensuring no interference from controlling parties[182]. Employee Management - The company reported a total of 267 employees, with 92 in production, 40 in sales, 53 in technology, 22 in finance, and 60 in administration[161]. - The company has a structured remuneration decision process based on its internal management system[150]. - The company has implemented a stable and competitive salary policy to maintain employee cohesion and motivation[162]. Future Outlook - The company provided guidance for the next fiscal year, projecting a revenue growth of 25% to 1.875 billion RMB[144]. - The company plans to implement cost-cutting measures aimed at reducing operational expenses by 15%[144]. - The company aims to enhance its innovation capabilities by leveraging big data and artificial intelligence technologies, focusing on the development of smart industry products[102].